Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|April 7, 2004

Philips expands CV partnership

Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac

Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac catheterization lab and StentBoost, a stent imaging interventional tool. Much of the work will be done in the Lenox Hill Heart and Vascular Institute of New York City. The new collaboration, the outgrowth of a 15-year partnership between Lenox and Philips, will focus on a new image processing algorithm and how it can be used with the Allura Xper FD10 cath lab. The goal is to provide enhanced images of the heart that show lesions in greater detail. Philips' StentBoost will also be evaluated to assess its utility in stent placement.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.